Jul 5, 2023 04:05PM
Jul 5, 2023 04:05PM
May 11, 2023 04:05PM
Mar 9, 2023 04:05PM
Mar 9, 2023 04:05PM
Jan 3, 2023 04:07PM
Jan 3, 2023 04:05PM Histogen Hires Alfred P. Spada Ph.D. as Executive Vice President and Chief Scientific Officer
Jan 3, 2023 04:05PM
Jul 27, 2022 02:30PM
Mar 10, 2022 04:05PM
Mar 10, 2022 04:05PM
Nov 8, 2021 04:05PM
Nov 8, 2021 04:05PM
Nov 2, 2021 08:00AM Histogen and Amerimmune Announce the Presentation of Emricasan Data in COVID-19 at the American College of Allergy, Asthma, and Immunology Conference
Nov 2, 2021 08:00AM
Aug 30, 2021 06:45AM
Aug 16, 2021 08:02AM
Aug 16, 2021 08:00AM
Aug 16, 2021 08:00AM
Aug 11, 2021 04:05PM
Aug 11, 2021 04:05PM Histogen Reports Second Quarter 2021 Earnings and Provides Business Update
Jun 22, 2021 08:00AM
Jun 22, 2021 08:00AM
May 19, 2021 08:04AM
May 19, 2021 08:00AM
May 19, 2021 08:00AM
Mar 16, 2021 08:03AM
Mar 16, 2021 08:00AM Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients
Mar 16, 2021 08:00AM
Mar 15, 2021 08:06AM
Mar 15, 2021 08:00AM
Mar 15, 2021 08:00AM
Mar 11, 2021 04:01PM
Mar 11, 2021 04:01PM
Dec 17, 2020 08:04AM Histogen Inc. (HSTO) Announces Filing Investigational NDA for HST-003
Dec 17, 2020 08:00AM
Dec 17, 2020 08:00AM
Nov 10, 2020 04:05PM
Nov 10, 2020 04:05PM
Oct 27, 2020 08:04AM
Oct 27, 2020 08:00AM
Oct 27, 2020 08:00AM Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
Sep 16, 2020 08:09AM
Sep 16, 2020 08:00AM
Sep 16, 2020 08:00AM
Aug 13, 2020 04:05PM
Aug 13, 2020 04:05PM
Jun 3, 2020 08:00AM
Jun 3, 2020 08:00AM Histogen to Present at BIO Digital 2020
Jun 1, 2020 08:02AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All